Davy James, Associate Editor

CVS and Prime Therapeutics agreements follow Express Scripts in hepatitis C formulary updates.

Government office cuts 16 drugs amid funding problems.

The British National Health Service announced yesterday that it will drop 16 cancer drugs from the list of treatments funded through its Cancer Drugs Fund.

Attacking protein could potentially treat a number of conditions, including the Ebola virus, brain cancer, and hepatitis.

Study finds many patients not receiving radiation treatment.

Supreme Court to decide legality of offering subsidies to low- and moderate-income people who purchase coverage through federally run health insurance marketplaces.

Most patients treated with high-dose immunosuppressive therapy and who had their own hematopoietic stem cells transplanted experienced sustained remission after 3 years.

Targeted therapy found to shrink tumor growth.

Side effects found to make it harder for patients to concentrate.

Filgrastim is indicated to decrease the incidence of infection in patients with non-myeloid malignancies who also are receiving myelosuppressive anti-cancer drugs.

Hepatitis B vaccination reduces incidence of primary liver cancer by 84% later in life, study finds.

Pharmaceutical manufacturing in the United States inched a step closer to a historic milestone today when the FDA Oncologic Drugs Advisory Committee recommended approval of the investigational biosimilar, filgrastim.

Drug currently being evaluated for treatment of hematological malignancies.

Specialty pharmacy is growing, and student pharmacists should keep abreast of the latest industry trends.

The FDA today granted orphan drug designation to an experimental drug that treats several types of blood cancers.

Research may lead to targeted therapeutic approach.

Researchers seek better targets for blocking events that lead to drug resistance.

Study finds disease leads to worse low and high frequency hearing.

Drug found to be as effective as current treatment without serious side effects.

Carfilzomib added to 2-drug combination produces longer remission period.

Adding a building block found in DNA could aid healthy cell production in cancer patients, study finds.

Study finds drawing blood can be a powerful therapeutic in extracorporeal photopherisis.

Combinations of drugs already approved found to be safe in treatment of rare disease.

Vaccine therapy stimulates immune defenses.

Study suggests drug has negative impact on immune system.

Multi-year agreement with AbbVie will place new drug as the exclusive option for patients with hepatitis C genotype 1.

Patients who received brentuximab vedotin post-transplant lived longer without disease progression than those on supportive care.

Study finds doctors shift health care services to Medicare when they can profit from doing so.

Nivolumab treats patients with unresectable or metastatic melanoma who no longer respond to other drugs.

Olaparib (Lynparza) was approved with companion diagnostic that detects mutations in BRCA genes.